Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bacon

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
International Immunology|December 11, 2008
Antagonism of CRTH2 ameliorates chronic epicutaneous sensitization-induced inflammation by multiple mechanismsStefen A Boehme, Edward P Chen, Karin Franz-Bacon, et al.
Nature|February 13, 1997
A new class of membrane-bound chemokine with a CX3C motifJ F Bazan, K B Bacon, G Hardiman, et al.
Kidney International|August 5, 1999
Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communicationL Feng, S Chen, G E Garcia, et al.
Transplantation Proceedings|December 26, 2001
FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokinesS Chen, K B Bacon, G Garcia, et al.
Hepatology Communications|November 23, 2023
Lysophosphatidic acid receptor 1 antagonist (EPGN2154) causes regression of NASH in preclinical NASH modelsJashdeep Bhattacharjee, Graham Beaton, Satheesh B Ravula, et al.
Blood|May 11, 1999
Human thymocytes express CCR-3 and are activated by eotaxinK Franz-Bacon, D J Dairaghi, S A Boehme, et al.
Journal of Leukocyte Biology|April 19, 2000
NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPSG E Garcia, Y Xia, S Chen, et al.
Nature|April 20, 2001
The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factorsJ Y Wu, L Feng, H T Park, et al.
Pulmonary Pharmacology & Therapeutics|February 1, 2014
A role for mitogen kinase kinase 3 in pulmonary inflammation validated from a proteomic approachT Holand, Y Riffo-Vasquez, D Spina, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 27, 2003
The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodentsNoriyuki Yamamoto, Keisuke Takeshita, Michitaka Shichijo, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
International Immunology|December 11, 2008
Antagonism of CRTH2 ameliorates chronic epicutaneous sensitization-induced inflammation by multiple mechanismsStefen A Boehme, Edward P Chen, Karin Franz-Bacon, et al.
Nature|February 13, 1997
A new class of membrane-bound chemokine with a CX3C motifJ F Bazan, K B Bacon, G Hardiman, et al.
Kidney International|August 5, 1999
Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communicationL Feng, S Chen, G E Garcia, et al.
Transplantation Proceedings|December 26, 2001
FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokinesS Chen, K B Bacon, G Garcia, et al.
Hepatology Communications|November 23, 2023
Lysophosphatidic acid receptor 1 antagonist (EPGN2154) causes regression of NASH in preclinical NASH modelsJashdeep Bhattacharjee, Graham Beaton, Satheesh B Ravula, et al.
Blood|May 11, 1999
Human thymocytes express CCR-3 and are activated by eotaxinK Franz-Bacon, D J Dairaghi, S A Boehme, et al.
Journal of Leukocyte Biology|April 19, 2000
NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPSG E Garcia, Y Xia, S Chen, et al.
Nature|April 20, 2001
The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factorsJ Y Wu, L Feng, H T Park, et al.
Pulmonary Pharmacology & Therapeutics|February 1, 2014
A role for mitogen kinase kinase 3 in pulmonary inflammation validated from a proteomic approachT Holand, Y Riffo-Vasquez, D Spina, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 27, 2003
The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodentsNoriyuki Yamamoto, Keisuke Takeshita, Michitaka Shichijo, et al.
Pageof 13